trial · primary record
ELX/TEZ/IVA
Cystic Fibrosis
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 297 |
| Primary completion | 2027-04-06 |
| Primary endpoint | Parts A and B: Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) |
| Registry ID | NCT05331183 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:45.425Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05331183
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.